ArticleMarine biotechnology (New York, N.Y.)2025
HcN13, a Fibroblast Growth Factor Binding Protein, Is Associated with Shell Formation in Hyriopsis cumingii.
Article in Marine biotechnology (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
Abstract
Fibroblast growth factor binding proteins (FGF-BPs) are involved in bone formation by binding to FGFs and modulating FGF signaling in vertebrates. Herein, a novel shell matrix protein gene, HcN13, was identified from the mussels Hyriopsis cumingii. Sequence analysis indicated that HcN13 belongs to the FGF-BP1 family. Quantitative real-time PCR and in situ hybridization analysis showed that HcN13 is expressed in the dorsal epithelial cells of the mantle center, indicating that HcN13 is a shell nacreous layer matrix protein. The expression of HcN13 in the mantle significantly increased during the regeneration of the prismatic and nacreous layers. Furthermore, the suppression of HcN13 at both the transcriptional and protein levels resulted in the complete destruction of the prisms and nacre tablets in vivo. However, the addition of SUMO-HcN13 did not affect the polymorphism and morphology of the crystals in vitro. These results indicated that HcN13 may serve as a modulator that influences downstream signaling pathways to further regulate shell formation. Additionally, HcN13 was highly expressed in hemocytes during pearl nacre disorder deposition and was also highly expressed in the mantle during pearl nacre order deposition, indicating that HcN13 is essential for pearl biomineralization. This study demonstrates, for the first time, the presence of FGF-BPs in the mollusk shell, highlighting their essential role in biomineralization in invertebrates.
Indexed as
Identifiers
40768099What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.